Elekta (OTCMKTS:EKTAY) Sets New 1-Year High – Still a Buy?

Elekta AB (OTCMKTS:EKTAY)’s stock price hit a new 52-week high on Wednesday . The stock traded as high as $6.53 and last traded at $6.53, with a volume of 5529 shares. The stock had previously closed at $6.42.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 16th. Three equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Elekta presently has a consensus rating of “Reduce”.

Elekta Stock Up 1.9%

The business’s fifty day moving average price is $5.61 and its 200 day moving average price is $5.23. The firm has a market capitalization of $2.41 billion, a price-to-earnings ratio of 93.51 and a beta of 1.04. The company has a current ratio of 1.04, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66.

Elekta (OTCMKTS:EKTAY) last issued its quarterly earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $427.85 million during the quarter, compared to analysts’ expectations of $436.91 million. Elekta had a net margin of 1.62% and a return on equity of 12.14%. On average, equities analysts expect that Elekta AB will post 0.36 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.